Education
About Us
Working with TipRanks
Follow Us
Kestra Medical Technologies Ltd. (KMTS)
NASDAQ:KMTS
KMTS Stock Chart & Stats
$22.85
--
Market closed
$22.85
--
Day’s Range― - ―
52-Week Range$13.25 - $30.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)310.69K
Market Cap
$1.34B
Enterprise Value$1.23B
Total Cash (Recent Filing)$175.42M
Total Debt (Recent Filing)$2.93M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Apr 20, 2026EPS Estimate
-0.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding58,349,052
10 Day Avg. Volume502,173
30 Day Avg. Volume310,694
Financial Highlights & Ratios
PEG Ratio-0.69
Price to Book (P/B)-5.17
Price to Sales (P/S)38.89
P/FCF Ratio-12.76
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue16.62
Enterprise Value/Gross Profit35.82
Enterprise Value/Ebitda-10.66
Forecast
1Y Price Target
$29.00Price Target Upside26.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical EvidencePost-approval and large real-world studies demonstrate consistent safety and effectiveness for the ASSURE wearable cardioverter defibrillator, which could encourage clinicians to broaden prescribing and boost market acceptance.
Financial Strength And MarginsImproving gross margin trends combined with a recent capital raise provide financial flexibility to fund commercialization efforts and support progress toward higher profitability.
Strategic PartnershipThe partnership with Biobeat Technologies could expand remote monitoring capabilities and open new clinical channels, supporting incremental adoption and market reach.
Bears Say
Investor And Execution UncertaintyAmbiguity around when guideline changes will occur increases execution risk for scaling sales and may heighten investor uncertainty, putting pressure on valuation until clarity emerges.
Regulatory/guideline Timing RiskUncertainty about the timing of guideline committee updates creates regulatory risk that could delay broader adoption and weaken expected prescription growth.
Kestra Medical Technologies Ltd. News
KMTS FAQ
What was Kestra Medical Technologies Ltd.’s price range in the past 12 months?
Kestra Medical Technologies Ltd. lowest stock price was $13.25 and its highest was $30.00 in the past 12 months.
What is Kestra Medical Technologies Ltd.’s market cap?
Kestra Medical Technologies Ltd.’s market cap is $1.34B.
When is Kestra Medical Technologies Ltd.’s upcoming earnings report date?
Kestra Medical Technologies Ltd.’s upcoming earnings report date is Apr 20, 2026 which is in 92 days.
How were Kestra Medical Technologies Ltd.’s earnings last quarter?
Kestra Medical Technologies Ltd. released its earnings results on Dec 11, 2025. The company reported -$0.64 earnings per share for the quarter, missing the consensus estimate of -$0.594 by -$0.046.
Is Kestra Medical Technologies Ltd. overvalued?
According to Wall Street analysts Kestra Medical Technologies Ltd.’s price is currently Undervalued.
Does Kestra Medical Technologies Ltd. pay dividends?
Kestra Medical Technologies Ltd. does not currently pay dividends.
What is Kestra Medical Technologies Ltd.’s EPS estimate?
Kestra Medical Technologies Ltd.’s EPS estimate is -0.6.
How many shares outstanding does Kestra Medical Technologies Ltd. have?
Kestra Medical Technologies Ltd. has 58,349,052 shares outstanding.
What happened to Kestra Medical Technologies Ltd.’s price movement after its last earnings report?
Kestra Medical Technologies Ltd. reported an EPS of -$0.64 in its last earnings report, missing expectations of -$0.594. Following the earnings report the stock price went up 5.058%.
Which hedge fund is a major shareholder of Kestra Medical Technologies Ltd.?
Currently, no hedge funds are holding shares in KMTS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kestra Medical Technologies Ltd. Stock Smart Score
Company Description
Kestra Medical Technologies Ltd.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
KMTS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in revenue and gross margin, supported by positive clinical study outcomes and an expanded sales force. However, the company continues to face challenges with net losses and operating expenses, along with the underpenetrated WCD market. Overall, the positive aspects of revenue growth and clinical validation outweigh the negatives.View all KMTS earnings summariesKMTS Stock 12 Month Forecast
Average Price Target
$29.00
▲(26.91% Upside)
Technical Analysis
AngioDynamics
―
Orasure Technologies
―
Staar Surgical
―
BioLife Solutions
―
Pulse Biosciences
―